Lundberg Sven Ante

Lundberg Sven Ante is listed in filings as Director at Q32 Bio Inc.. This profile follows SEC Form 4 activity through Jan 30, 2026, including 31 public disclosures. Recent filings connect the profile to Q32 Bio Inc. (QTTB), Merus N.V. (MRUS), and Vor Biopharma Inc. (VOR). The current snapshot covers public activity from Sep 27, 2024 to Jan 30, 2026. Reported amounts are shown as $73.3K to $12.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.